Peter Bloch

Peter David Bloch was the founder of Tribute Pharmaceuticals, Inc., founded in 2005, where the title held was Chief Financial Officer from 2005 to 2007.
Current jobs include Chief Executive Officer at Wembley Advisors Corp.
since 2018; Director at Hb Agri Products, Inc. since 2014; President, Treasurer & Director at Bionik Mergerco, Inc.; Director at InnoCan Pharma Corp.
since 2020; Director at Seegnal, Inc. since 2025; Director at Arway Corp.
since 2024; Director at Toggle3D.ai, Inc. since 2024; and Chief Financial Officer at Ontario Energy Savings Corp.
Former jobs include Chairman & Chief Executive Officer at Bionik Laboratories, Inc. from 2012 to 2018; Chief Executive Officer at Bresotec, Inc. from 2018 to 2023; Director at Environmental Solutions Worldwide, Inc. from 2010 to 2011; Director at Walmer Capital Corp.
in 2011; Director at Bionik Laboratories Corp.
in 2018; Director at EnerSpar Corp.; Director at Reem Capital Corp.; Chief Financial Officer at Energy Savings Income Fund from 2008 to 2009; Chief Financial Officer & VP-Administration at Gennum Corp.
in 2005; Chief Financial Officer at Just Energy (U.S.) Corp.
in 2009; Chief Financial Officer at Just Energy Group, Inc. from 2007 to 2009; Partner at Guarden Capital, Inc. in 2011; and Chief Executive & Financial Officer at Sanofi Canada, Inc. Education includes an undergraduate degree from the University of Cape Town, conferred in 1982.